Nitric Oxide-Releasing Hemodialysis Catheter Lock Solutions
ACS Applied Materials & Interfaces · 21.06.2023 · 15 (24) · 28907-28921
DOI: 10.1021/acsami.3c02506 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 07.06.2023. Verfasst von Sara E Maloney und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States. Hauptthemen laut MEDLINE: Catheter-Related Infections, Central Venous Catheters, Thrombosis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 71 Literaturangaben. Gefördert von: Division of Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, Eshelman Institute for Innovation, University of North Carolina at Chapel Hill.
Abstract (Originalsprache)
In an attempt to address the significant morbidity, mortality, and economic cost associated with tunneled dialysis catheter (TDC) dysfunction, we report the development of nitric oxide-releasing dialysis catheter lock solutions. Catheter lock solutions with a range of NO payloads and release kinetics were prepared using low-molecular-weight N-diazeniumdiolate nitric oxide donors. Nitric oxide released through the catheter surface as a dissolved gas was maintained at therapeutically relevant levels for at least 72 h, supporting clinical translatability (interdialytic period). Slow, sustained NO release from the catheter surface prevented bacterial adhesion in vitro by 88.9 and 99.7% for Pseudomonas aeruginosa and Staphylococcus epidermidis, respectively, outperforming a burst NO-release profile. Furthermore, bacteria adhered to the catheter surface in vitro prior to lock solution use was reduced by 98.7 and 99.2% for P. aeruginosa and S. epidermidis, respectively, when using a slow releasing NO donor, demonstrating both preventative and treatment potential. The adhesion of proteins to the catheter surface, a process often preceding biofilm formation and thrombosis, was also lessened by 60-65% by sustained NO release. In vitro cytotoxicity of catheter extract solutions to mammalian cells was minimal, supporting the non-toxic nature of the NO-releasing lock solutions. The use of the NO-releasing lock solution in an in vivo TDC porcine model demonstrated decreased infection and thrombosis, enhanced catheter functionality, and improved outcome (i.e., likelihood of survival) as a result of catheter use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
- UNC Kidney Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
- Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
ORCID-Profile: Sara E Maloney, Mark H Schoenfisch
Förderung
- Division of Chemistry
- National Institute of Diabetes and Digestive and Kidney Diseases
- Eshelman Institute for Innovation, University of North Carolina at Chapel Hill
- KnowBio, LLC
- UNC Kidney Center
Zitieren
APA
Maloney, S. E., Grayton, Q. E., Wai, C., Uriyanghai, U., Sidhu, J., Roy-Chaudhury, P., & Schoenfisch, M. H. (2023). Nitric Oxide-Releasing Hemodialysis Catheter Lock Solutions. ACS Applied Materials & Interfaces, 15(24), 28907-28921. https://doi.org/10.1021/acsami.3c02506
Vancouver
Maloney SE, Grayton QE, Wai C, Uriyanghai U, Sidhu J, Roy-Chaudhury P, et al. Nitric Oxide-Releasing Hemodialysis Catheter Lock Solutions. ACS Applied Materials & Interfaces. 2023;15(24):28907-28921. doi:10.1021/acsami.3c02506
BibTeX
@article{Maloney2023,
author = {Maloney, Sara E and Grayton, Quincy E and Wai, Christine and Uriyanghai, Unimunkh and Sidhu, Jasleen and Roy-Chaudhury, Prabir and Schoenfisch, Mark H},
title = {Nitric Oxide-Releasing Hemodialysis Catheter Lock Solutions},
journal = {ACS Applied Materials & Interfaces},
year = {2023},
volume = {15},
number = {24},
pages = {28907--28921},
doi = {10.1021/acsami.3c02506}
}
EUVIMED